Home » Topics » BioWorld Science

BioWorld Science
RSS

DIO2 is a regulator of mitochondrial activity in developing human cardiomyocytes

July 7, 2021

Aston Sci studies AST-021p for advanced solid tumors in phase I

July 7, 2021

BNC-210 advances into phase IIb trial in PTSD

July 6, 2021

HIV rebound biomarkers give insights into controllers and, unexpectedly, comorbidities

July 6, 2021

HUTCHMED initiates phase I study of HMPL-295 in advanced solid tumors

July 6, 2021

Downregulation of ERBB4 leads to peripartum cardiomyopathy

July 6, 2021

Phase I/II trial explores Gadeta's gamma delta TCR cell therapy GDT-002 for multiple myeloma

July 6, 2021

Phase II FORCE study of avdoralimab in COVID-19 misses primary endpoints

July 6, 2021

Bio-ADM, a novel biomarker of congestion in acute dyspnea

July 6, 2021

SYNB-1934, optimized live bacterial therapeutic for the treatment of phenylketonuria

July 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...